Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune DisordersDouglas B. Johnson, Joseph I. Clark, Patrick A. Ott et al.|JAMA Oncology|2015Cited by 656
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumorsElizabeth J. Davis, Janice M. Mehnert, Jennifer Pulini et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 93